An Upper Gastrointestinal Endoscopic Study of fifty cases of cirrhosis liver

Abstract

Cirrhosis liver is a common, often progressive and usually fatal disorder. Upper gastrointestinal (UGI) bleeding is a leading cause of death in patients with liver cirrhosis. In most cases the hemorrhage originates from EV or from CG. The average risk of bleeding in cirrhotic patients with EV who have not bled previously is 30%. The mortality rate is twice of an EV bleed than that of a non EV UGI bleed in cirrhotic and there is 40%  risk of death in the initial episode with 50% moratliy at 6 weeks and only 30%  survivial at one year. This high mortality rate is the rationale for the prophylaxis. UGI lesions lend them selves to an easy diagnosis and management by UGI endoscopy. A lot of emphasis is being placed on both primary prophylactic sclerotherapy or slcerotherapy after the first bleed to prevent the rebleed.